Stock Events

Stock Events

Viking Therapeutics (VKTX) Q3 2026 Earnings

29JulConfirmed

Q4 2025

Q1 2026

Q2 2026

Q3 2026

-1.38

-1.16

-0.93

-0.71

Details

Expected EPS

-1.23275

Actual EPS

-1.1

Surprise EPS

0.13

Surprise Percent

+10.77%

Description

Viking Therapeutics (VKTX) has reported earnings of -1.1 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.